Literature DB >> 18293019

A serosurvey of Anaplasma phagocytophilum in blood donors in Crete, Greece.

D Chochlakis1, A Papaeustathiou, G Minadakis, A Psaroulaki, Y Tselentis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18293019     DOI： 10.1007/s10096-007-0457-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  8 in total

1.  First long-term study of the seroresponse to the agent of human granulocytic ehrlichiosis among residents of a tick-endemic area of Sweden.

Authors:  B Wittesjö; A Bjöersdorff; I Eliasson; J Berglund
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-03       Impact factor: 3.267

2.  Serological evidence for human granulocytic ehrlichiosis in Western Austria.

Authors:  G Walder; G Tiwald; M P Dierich; R Würzner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-21       Impact factor: 3.267

3.  Seroprevalence of human granulocytic ehrlichiosis in high-risk groups in Denmark.

Authors:  S Skarphédinsson; P Søgaard; C Pedersen
Journal:  Scand J Infect Dis       Date:  2001

4.  Serologic evidence of ehrlichiosis among humans and wild animals in The Netherlands.

Authors:  J Groen; P Koraka; Y A Nur; T Avsic-Zupanc; W H F Goessens; A Ott; A D M E Osterhaus
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-01       Impact factor: 3.267

5.  Guidelines for the diagnosis of tick-borne bacterial diseases in Europe.

Authors:  P Brouqui; F Bacellar; G Baranton; R J Birtles; A Bjoërsdorff; J R Blanco; G Caruso; M Cinco; P E Fournier; E Francavilla; M Jensenius; J Kazar; H Laferl; A Lakos; S Lotric Furlan; M Maurin; J A Oteo; P Parola; C Perez-Eid; O Peter; D Postic; D Raoult; A Tellez; Y Tselentis; B Wilske
Journal:  Clin Microbiol Infect       Date:  2004-12       Impact factor: 8.067

6.  Human granulocytic ehrlichiosis in southern Germany: increased seroprevalence in high-risk groups.

Authors:  V Fingerle; J L Goodman; R C Johnson; T J Kurtti; U G Munderloh; B Wilske
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

7.  Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.

Authors:  S M Chen; J S Dumler; J S Bakken; D H Walker
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

8.  Serologic evidence of human granulocytic ehrlichiosis, Greece.

Authors:  Stella Alexiou Daniel; Katerina Manika; Malamatenia Arvanitidou; Eudoxia Diza; Nikolaos Symeonidis; Antonis Antoniadis
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883
  8 in total
  3 in total

1.  Human Exposure to Anaplasma phagocytophilum in Two Cities of Northwestern Morocco.

Authors:  Sarah Elhamiani Khatat; Hamid Sahibi; Mony Hing; Ismail Alaoui Moustain; Hamid El Amri; Mohammed Benajiba; Malika Kachani; Luc Duchateau; Sylvie Daminet
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

2.  Seroprevalence of six pathogens transmitted by the Ixodes ricinus ticks in asymptomatic individuals with HIV infection and in blood donors.

Authors:  Agnieszka Pawełczyk; Małgorzata Bednarska; Justyna D Kowalska; Beata Uszyńska-Kałuża; Marek Radkowski; Renata Welc-Falęciak
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

Review 3.  Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis.

Authors:  Rachael J Thomas; J Stephen Dumler; Jason A Carlyon
Journal:  Expert Rev Anti Infect Ther       Date:  2009-08       Impact factor: 5.854
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.